TB-500

What it is

Thymosin Beta-4 (Tβ4) is one of the most abundant peptides in mammalian tissue, with particularly high concentrations found in platelets and wound fluid. TB-500 represents its active fragment — a 17-amino acid sequence (Ac-LKKTETQ) corresponding to the actin-binding domain responsible for much of its biological activity. It was first isolated from the thymus but is now understood to be expressed systemically. TB-500 has a molecular weight of 2888.2 g/mol, making it substantially larger than BPC-157 but well within the range of routinely synthesised research peptides.

How it works

TB-500's primary mechanism involves sequestering G-actin monomers, thereby regulating actin dynamics throughout the cell. By controlling the balance between free G-actin and polymerised F-actin, TB-500 influences cell shape, migration, and division. Research has demonstrated effects on endothelial cell and keratinocyte migration — both critical to wound closure — as well as the formation of new blood vessels (angiogenesis) and reduction of pro-inflammatory cytokines including IL-6 and TNF-alpha. Its effects in cardiac repair models are particularly notable: studies have demonstrated regeneration of cardiac muscle tissue and angiogenesis in ischaemic models, effects that are not typically observed with conventional peptides.

Research context

Research has examined TB-500 in models of cardiac repair after infarction, tendon and muscle injury, corneal wound healing, skin repair, and hair follicle stimulation. A landmark study published in the Journal of Molecular and Cellular Cardiology demonstrated that Thymosin Beta-4 could stimulate adult epicardial progenitor cells to differentiate into cardiomyocytes following ischaemic injury — a finding that generated significant interest in regenerative medicine research. TB-500 is frequently studied together with BPC-157 in recovery-focused research, with the two compounds showing complementary mechanisms.